Search Results - "Kang, Y.K."

Effects of myosin heavy chain isoforms on meat quality, fatty acid composition, and sensory evaluation in Berkshire pigs by Kang, Y.K., Choi, Y.M., Lee, S.H., Choe, J.H., Hong, K.C., Kim, B.C.

“…The main objective of this study was to investigate the effects of myosin heavy chain (MHC) isoforms on meat and sensory quality in Berkshire pigs. A total of…”
Get full text

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010 by VAN CUTSEM, E, DICATO, M, GROTHEY, A, HALLER, D, HAUSTERMANS, K, KERR, D, NORDLINGER, B, MARSHALL, J, MINSKY, B. D, KANG, Y. K, LABIANCA, R, LORDICK, F, GEVA, R, OHTSU, A, PAVLIDIS, N, ROTH, A, ROUGIER, P, SCHMOLL, H. J, SOBRERO, A, TABERNERO, J, VAN DEVELDE, C, ZALCBERG, J, ARBER, N, BANG, Y, BENSON, A, CERVANTES, A, DIAZ-RUBIO, E, DUCREUX, M, GLYNNE-JONES, R

“…Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal…”
Get full text

2295 Phase 2 study of vorinostat combined with capecitabine plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (AGC) by Yoo, C, Ryu, M.H, Na, Y.S, Park, S.R, Lee, C.W, Ryoo, B.Y, Kang, Y.K

Get full text

2406 The prognostic impact of FGFR2 gene amplification in patients receiving fiuoropyrimidine and platinum (FP) chemotherapy for with metastatic and locally advanced gastric cancers by Seo, S, Park, S.J, Park, S.R, Ryu, M.H, Ryoo, B.Y, Park, Y.S, Na, Y.S, Lee, C.W, Lee, J.K, Kang, Y.K

Get full text

2307 Phase II study of neoadjuvant chemotherapy with docetaxel, capecitabine, cisplatin and bevacizumab for initially unresectable gastric cancer with invasion of adjacent organs or paraaortic lymph node metastasis by Kim, J.H, Park, S.R, Ryu, M.H, Ryoo, B.Y, Kim, K.P, Su Kim, Beom, Yoo, M.W, Yook, J.H, Sik Kim, Byung, Kang, Y.K

Get full text

First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848) by Gazzah, A, Stjepanovic, N, Ryu, M.H, Tabernero, J, Soria, J.C, Bedard, P, Kang, Y.K, Bahleda, R, Guillemin-Paveau, H, Henry, C, Hatteville, L, Zilocchi, C, Demers, B, Hierro, C

“…An abstract of the study by Gazzah et al evaluating the first-in-human phase I trial of the anti-CEACAM5 antibody-drug conjugate SAR408701 in patients with…”
Get full text

Establishment and characterization of pairs of patient-derived cells and xenograft models of gastrointestinal stromal tumors resistant to standard tyrosine kinase inhibitors by Na, Y.S, Ryu, M.H, Park, S.R, Lee, J.K, Lee, C.W, Park, J.M, Shin, Y.K, Ku, J.L, Lee, S.Y, Ahn, S.M, Kang, Y.K

“…Standard of therapy for patients with gastrointestinal stromal tumor (GIST) includes imatinib, sunitinib and regorafenib. However, most patients eventually…”
Get full text

2364 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced gastric or gastroesophageal junction cancer: A phase Ib trial by Chung, H.C, Arkenau, H.T, Wyrwicz, L, Oh, D.Y, Lee, K.W, Infante, J.R, Chin, K, Von Heydebreck, A, Kang, Y.K, Safran, H

Get full text

2308 Association between CYP2A6 polymorphisms and treatment outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer by Jeong, J.H, Park, S.R, Ryu, M.H, Ryoo, B.Y, Kong, S.Y, Yook, J.H, Yoo, M.W, Su Kim, Beom, Oh, S.T, Kim, Byung Sik, Kang, Y.K

Get full text

Transparent amorphous In–Ga–Zn–O thin film as function of various gas flows for TFT applications by Jung, C.H., Kim, D.J., Kang, Y.K., Yoon, D.H.

“…The electrical and optical properties of amorphous indium gallium zinc oxide (a-IGZO) films, which can be used as a channel layer, deposited by radio frequency…”
Get full text

64. EORTC-1203: Integration of trastuzumab, with or without pertuzumab, into perioperative chemotherapy of HER-2 positive stomach cancer: INNOVATION EudraCT number 2014-000722-38; NCT02205047 by Wagner, A.D, Kang, Y.K, Van Dieren, J, Mauer, M, Grabsch, H, Caballero, C, Kataoka, K, Atasoy, A, Cho, J.Y, Mohler, M, Roth, A, Salto-Tellez, M, Langer, R, Schuhmacher, C, Van Sandick, J, Van Grieken, N, Lordick, F

Get full text

217 Results of a phase I, open-label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumour activity of AZD9150 in patients with advanced/metastatic hepatocellular carcinoma by Kang, Y.K, Ryoo, B.Y, Kim, T.Y, Lee, K.H, Lim, H.Y, Lee, S.J, Ikeda, M, Okusaka, T, Nadano, S, Lin, C.C, Poon, T.P, Yen, C.J, McCoon, P, Neumann, F, Vishwantahan, K, DuPont, R, Lyne, P

Get full text

501 Immunological STAT3 knockdown associated with anti-tumor activity in pre-clinical models translates to clinical samples, suggesting immune modulation contributes to the clinical activity of AZD9150, a therapeutic STAT3 ASO by McCoon, P, Woessner, R, DuPont, R, Bell, K, Collins, M, Pablo, L, Lawson, D, Nadella, P, Jacobs, V, Womack, C, Reimer, C, Hong, D, Nemunaitis, J, Kang, Y.K, Kim, T.Y, Lim, H.Y, Okusaka, T, Nadano, S, Lin, C.C, Lyne, P

Get full text

488 A Combination of Surrogate and Tumor Biopsy Biomarker Data Demonstrates JAK Pathway Inhibition by AZD1480 in Phase I Patient Samples by McCoon, P, Eder, J.P, Huszar, D, McEachern, K, Schroeder, P, Tang, W, Womack, C, Kang, Y.K, Eckhardt, S.G

Get full text

IL-23 promotes osteoclastogenesis in osteoblast-osteoclast co-culture system by Kang, Y.K., Zhang, M.C.

Get full text

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer by Kim, T. W., Chang, H. M., Kang, H. J., Lee, J. R., Ryu, M. H., Ahn, J. H., Kim, J. H., Lee, J. S., Kang, Y. K.

“…Background: A phase II study was conducted to assess the efficacy and tolerability of substituting capecitabine for 5-fluorouracil in combination with…”
Get full text

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer by Kim, T. W., Kang, Y. K., Ahn, J. H., Chang, H. M., Yook, J. H., Oh, S. T., Kim, B. S., Lee, J. S.

“…Background: A phase II study was conducted to assess the efficacy and tolerability of combination therapy with capecitabine and cisplatin in patients with…”
Get full text

Nuclear reprogramming of cloned embryos produced in vitro by Han, Y.M, Kang, Y.K, Koo, D.B, Lee, K.K

“…Despite the fact that cloned animals derived from somatic cells have been successfully generated in a variety of mammalian species, there are still many…”
Get full text

6156 POSTER Noninvasive Measurements From Computed Tomography and Laboratory Results Predict Hepatic Sinusoidal Injury Associated With Oxaliplatin-based Chemotherapy in Patients With Metastatic Colorectal Cancer by Hong, Y.S, Kim, D.Y, Park, S.H, Kim, K.P, Lee, J.L, Ryu, M.H, Chang, H.M, Ryoo, B.Y, Kang, Y.K, Kim, T.W

Get full text

9421 POSTER Optimizing Management of Sunitinib Treatment in a Worldwide Treatment-use Trial of Patients (Pts) With Advanced Gastrointestinal Stromal Tumour (GIST) by Reichardt, P, Kang, Y.K, Rutkowski, P, Schuette, J, Rosen, L.S, Seddon, B, Yalcin, S, Chen, L, Fly, K, Demetri, G.D

Get full text